Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
CRISPR Therapeutics to Present at the 2022 BMO Growth & ESG Conference
08:00am, Thursday, 01'st Dec 2022
ZUG, Switzerland and BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious disea
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
07:45am, Monday, 28'th Nov 2022
Cathie Wood makes big bets on potential huge winners. But Ark Invest's top 10 holdings, including Tesla and Roku, have tumbled in 2022.
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
05:52am, Friday, 25'th Nov 2022
The ARK Invest founder might regret trimming her position in this biotech stock.
Crispr Therapeutics Stock: Bull vs. Bear
06:30am, Tuesday, 15'th Nov 2022
Crispr shares have fallen about 20% so far this year.
3 Healthcare Stocks That Could Go Parabolic
05:30am, Wednesday, 09'th Nov 2022
These beaten-down stocks are ready for a rebound.
CRISPR Therapeutics (CRSP) Q3 Earnings Top, Sales Lag Estimates
02:18pm, Wednesday, 02'nd Nov 2022
CRISPR Therapeutics (CRSP) third-quarter 2022 loss is narrower than expected, while sales miss estimates.
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
06:50pm, Tuesday, 01'st Nov 2022
CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 2.61% and 97.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto
Better Buy: CRISPR Therapeutics vs. Bluebird Bio
09:30am, Thursday, 27'th Oct 2022
These two companies have performed almost equally poorly on the stock market in the past year.
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
08:00am, Saturday, 22'nd Oct 2022
S&P 500 giant Vertex and Cheniere Energy, the largest U.S. liquefied natural gas producer, are setting up bullishly in the bear market. The post S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Str
The Top 5 Stocks Cathie Wood Bought and Sold This Week
05:10pm, Friday, 21'st Oct 2022
It has been another volatile week for Cathie Wood's flagship exchange-traded fund (ETF), the ARK Innovation ETF (NYSEARCA: ARKK ). Shares of ARKK recently hit a five-year low and 52-week low of $33.74
2 Budding Growth Stocks That Could Turn $1,000 Into $10,000 in 8 Years
10:15am, Friday, 21'st Oct 2022
They're both using unique and highly efficient approaches to developing and deploying their medicines.
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
10:14am, Thursday, 20'th Oct 2022
Despite CRISPR stocks' enthusiasm, the risk of potential cures continues to cloud market projections for new gene-editing treatments moving through the pipeline toward FDA approval. The post CRISPR St
2 Under-the-Radar Biotech Stocks to Buy in 2022
09:53am, Wednesday, 19'th Oct 2022
These two drugmakers are growing in prominence.
3 Cathie Wood Stocks to Buy and Hold for 10 Years
09:23am, Wednesday, 19'th Oct 2022
The risks are formidable, but the chances of a massive gain are too much to pass up.
CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
08:05am, Wednesday, 05'th Oct 2022
ZUG, Switzerland and BOSTON, Oct. 05, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious disea
